XTXXF — Adastra Holdings Ltd.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1891512 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-10-01
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 4,743,954 | 1,341,665 | -345,863 | -636,870 | 16,008,511 | 786,599 | 16,955,763 |
| Jun 2025 | 2,908,635 | 1,110,402 | -875,040 | -1,079,890 | 16,181,440 | 435,662 | 16,496,446 |
| Mar 2025 | 4,471,979 | 1,557,415 | -392,426 | -684,851 | 16,927,977 | 160,511 | 16,163,094 |
| Dec 2024 | 4,737,562 | 1,587,712 | -817,851 | -12,090,560 | 19,342,244 | 1,296,727 | 17,892,510 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-212,084
Investing CF
$-714,539
Financing CF
$-204,491
CapEx
$-116,543
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.42
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-37,386,430
Inventory
$3,727,043
Receivables
$1,773,557
ST Investments
—
EBIT TTM
$-13,907,657
Pretax Income TTM
$-15,085,170
Interest Exp TTM
$1,177,513
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$16,862,130
EBITDA
$-2,037,634
Free Cash Flow
$761,236
Enterprise Value
$2,823,971
Total Cash
$786,599
Total Debt
$3,571,391
Shares Out
5,597,050
Trailing EPS
$-1.84
Book Value
$-0.12
ROE
-230.1%
ROA
-6.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 24,843,381 | -971,702 | -13,235,414 | 19,342,244 | 17,892,510 | 1,449,734 | 826,231 |
| Dec 2023 | 22,222,645 | -1,793,759 | -3,544,642 | 32,342,771 | 17,657,623 | 14,685,148 | 1,861,263 |
| Dec 2022 | 13,295,078 | -799,996 | -4,281,639 | 31,803,945 | 13,574,155 | 18,229,790 | 916,911 |
| Dec 2021 | 5,628,616 | -2,391,738 | -2,749,939 | 28,755,450 | 6,382,734 | 22,372,716 | -1,054,093 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.02T | $1142.85 | — |
| JNJ | JOHNSON & JOHNSON | $617.01B | $256.03 | — |
| ABBV | AbbVie Inc. | $464.43B | $262.82 | — |
| MRK | Merck & Co., Inc. | $356.01B | $144.30 | — |
| NVS | NOVARTIS AG | $268.00B | $141.00 | — |
News headlines (Yahoo Finance, 1h cache)
Adastra Holdings Ltd. Appoints New Director
2026-05-04 09:00 · Yahoo
Adastra Holdings Announces Resignation of Director
2026-04-29 20:00 · Yahoo
Adastra Holdings Enters into Agreements to Sell Subsidiaries
2025-10-09 03:28 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.